To treat diffuse massive B-cell lymphoma, not otherwise specified, or substantial B-cell lymphoma arising from follicular lymphoma soon after two or even more lines of systemic therapy This notification is not really mandatory; even so, the FDA strongly encourages companies to Speak to the company and Stick to the https://frankn495cuk1.wikiconverse.com/user